AIA is a cutting-edge AI model developed and fine-tuned to mirror Invivo’s investment logic, decision-making patterns, and evaluation framework across the life sciences and biotech sectors.
Designed as an extension of our analytical capabilities, AIA supports the team by:
- Analyzing investment decks through structured gap assessments and generating targeted key questions.
- Building competitor landscapes with detailed 20-page reports.
- Profiling CEOs and founders, highlighting key career milestones and strategic relevance.
- Performing valuation analyses to benchmark companies and assess market positioning.
- Mapping European scientific talent across specific therapeutic areas and modalities.
- Producing comprehensive research reports on emerging technologies, complete with references and citations.
AIA enables Invivo to combine data-driven insight with domain expertise, enhancing the depth, speed, and consistency of our investment process.